Science and Technology of Breast Implants: New Challenges for the Practicing Clinician in Cosmetic and Reconstructive Breast Surgery Sat, Sep 21 4:30-6:00 p.m.

The science and technology of breast implants has advanced so rapidly that information presented at our PSTM 2018 panel is no longer current. New publications (September-October 2018) have revived the issue of a connection between gel implants and autoimmune disease.

Despite the thorough investigation conducted from 1991 - 2007, including an FDA mandated moratorium on gel devices, new concerns have arisen that challenge best practice guidelines and patient disclosure.

The panel will also review data regarding established techniques of direct to implant breast reconstruction and newer methods of prepectoral reconstruction in order to determine indications and best results.

At the end of this activity participants will be able to:

  1. Identify new information regarding concerns linking implants to autoimmune disease and be able to discuss these risks with patients
  2. Determine whether textured implants have a role in reconstructive or cosmetic breast surgery in view of current knowledge of breast implant associated anaplastic large cell lymphoma (BIA-ALCL)
  3. Recognize the different implant products and understand differences in shape, fill volume, encapsulation rates, rupture rates, and gel cohesivity. Participants will be able to outline appropriate follow-up program of breast imaging, including MRI testing, in patients having breast surgery with implants.
  4. Identify patients who are candidates for direct to implant or prepectoral breast reconstruction
  5. Identify techniques for enhancement of both the breast cosmetic and reconstructive result using fat grafting and acellular dermal matrix.

Program Subject to Change.

Accreditation: The American Society of Plastic Surgeons® (ASPS) is accredited by the Accreditation Council for Continuing Education to provide continuing medical education for physicians.

Designation: The ASPS designates this live activity for a maximum of 1.5 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.